Trial Profile
The Effects of Cyclosporin A Emulsion, (Restasis), on the Ocular Surface in Response to Low Humidity Environment in Patients With Dry Eye
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 21 Feb 2020
Price :
$35
*
At a glance
- Drugs Ciclosporin (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- 22 Jan 2020 Status changed from completed to discontinued.
- 19 Jul 2016 Status changed from recruiting to completed.
- 12 Jan 2016 Planned End Date changed from 1 Jun 2015 to 1 Dec 2016, according to ClinicalTrials.gov record.